test

Ron Rosenstraus

@Eversept Partners, Lp

Latest period2024 - Q3ReportedManaged Assets$1.46BTotal holdings67
Assets growth rate-0.03%Assets growth rate (2-Q avg)-1.3%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Eversept Partners, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 67 positions.

Assets under management

The assets under management (AUM) of Eversept Partners, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.46B in assets, with a quarterly growth rate of -0.03% and a 2-quarter average growth rate of -1.3%. The portfolio is managed by Ron Rosenstraus, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MLTXMoonlake Immunotherapeutics
Recent Activity
Exited
0%
$3.148M
71,596 shares@ $43.97 avg price
GHGuardant Health Inc
Recent Activity
Exited
0%
$2.87M
99,377 shares@ $28.89 avg price
IMVTImmunovant Inc
Recent Activity
Exited
0%
$2.453M
92,909 shares@ $26.41 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
Exited
0%
$1.949M
286,266 shares@ $6.81 avg price
FULCFulcrum Therapeutics Inc
Recent Activity
Exited
0%
$948,383
152,965 shares@ $6.2 avg price
GTHXG1 Therapeutics Inc
Recent Activity
Exited
0%
$455,916
199,963 shares@ $2.29 avg price
MCRBSeres Therapeutics Inc
Recent Activity
Exited
0%
$302,699
418,208 shares@ $0.73 avg price